AB&B Bio-Tech Co. Ltd. JS Files Director List with HKEX

Reuters2025-12-23

AB&B Bio-Tech Co. Ltd. JS Files Director List with HKEX

AB&B Bio-Tech Co. Ltd. JS (Stock Code: 2627), a joint stock company established in the People’s Republic of China, has filed its updated list of directors and their roles to the Hong Kong Stock Exchange. The Board consists of Executive Directors Mr. An Youcai (Chairman), Ms. Li Runxiang, and Mr. He Yiming; Non-executive Directors Mr. Cheng Qianwen, Mr. Yu Jianlin, and Mr. Du Mu; and Independent Non-executive Directors Mr. Li Xiangming, Mr. Li Jianjun, and Mr. Chen Chengbei. The company’s board committees are structured as follows: Mr. Li Jianjun chairs the Audit Committee with Mr. Cheng Qianwen and Mr. Li Xiangming as members. Mr. Chen Chengbei chairs the Remuneration and Appraisal Committee, with Ms. Li Runxiang and Mr. Li Jianjun as members. Mr. Li Xiangming chairs the Nomination Committee, with Ms. Li Runxiang and Mr. Chen Chengbei as members. The Strategy Committee is chaired by Mr. An Youcai, with Mr. Cheng Qianwen and Mr. Li Xiangming as members.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&B Bio-Tech Co. Ltd. JS published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251223-11965407), on December 23, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2593491851?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-23 18:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2593491851","market":"us","top_or_hot":-1,"title":"AB&B Bio-Tech Co. Ltd. JS Files Director List with HKEX","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      AB&amp;B Bio-Tech Co. Ltd. JS Files Director List with HKEX\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        AB&amp;B Bio-Tech Co. Ltd. JS (Stock Code: 2627), a joint stock company established in the People’s Republic of China, has filed its updated list of directors and their roles to the Hong Kong Stock Exchange. The Board consists of Executive Directors Mr. An Youcai (Chairman), Ms. Li Runxiang, and Mr. He Yiming; Non-executive Directors Mr. Cheng Qianwen, Mr. Yu Jianlin, and Mr. Du Mu; and Independent Non-executive Directors Mr. Li Xiangming, Mr. Li Jianjun, and Mr. Chen Chengbei. The company’s board committees are structured as follows: Mr. Li Jianjun chairs the Audit Committee with Mr. Cheng Qianwen and Mr. Li Xiangming as members. Mr. Chen Chengbei chairs the Remuneration and Appraisal Committee, with Ms. Li Runxiang and Mr. Li Jianjun as members. Mr. Li Xiangming chairs the Nomination Committee, with Ms. Li Runxiang and Mr. Chen Chengbei as members. The <a href=\"https://laohu8.com/S/MSTR\">Strategy</a> Committee is chaired by Mr. An Youcai, with Mr. Cheng Qianwen and Mr. Li Xiangming as members.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&amp;B Bio-Tech Co. Ltd. JS published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251223-11965407), on December 23, 2025, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AB&B Bio-Tech Co. Ltd. JS Files Director List with HKEX</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAB&B Bio-Tech Co. Ltd. JS Files Director List with HKEX\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-23 18:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      AB&amp;B Bio-Tech Co. Ltd. JS Files Director List with HKEX\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        AB&amp;B Bio-Tech Co. Ltd. JS (Stock Code: 2627), a joint stock company established in the People’s Republic of China, has filed its updated list of directors and their roles to the Hong Kong Stock Exchange. The Board consists of Executive Directors Mr. An Youcai (Chairman), Ms. Li Runxiang, and Mr. He Yiming; Non-executive Directors Mr. Cheng Qianwen, Mr. Yu Jianlin, and Mr. Du Mu; and Independent Non-executive Directors Mr. Li Xiangming, Mr. Li Jianjun, and Mr. Chen Chengbei. The company’s board committees are structured as follows: Mr. Li Jianjun chairs the Audit Committee with Mr. Cheng Qianwen and Mr. Li Xiangming as members. Mr. Chen Chengbei chairs the Remuneration and Appraisal Committee, with Ms. Li Runxiang and Mr. Li Jianjun as members. Mr. Li Xiangming chairs the Nomination Committee, with Ms. Li Runxiang and Mr. Chen Chengbei as members. The <a href=\"https://laohu8.com/S/MSTR\">Strategy</a> Committee is chaired by Mr. An Youcai, with Mr. Cheng Qianwen and Mr. Li Xiangming as members.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&amp;B Bio-Tech Co. Ltd. JS published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251223-11965407), on December 23, 2025, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02627","symbol_name":"中慧生物-B","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDL4Z0RHr:1","article_id":"2593491851","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2593491851","pubTimestamp":1766486102,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"AB&B Bio-Tech Co. Ltd. JS , a joint stock company established in the People’s Republic of China, has filed its updated list of directors and their roles to the Hong Kong Stock Exchange. The Board consists of Executive Directors Mr. An Youcai , Ms. Li Runxiang, and Mr. He Yiming; Non-executive Directors Mr. Cheng Qianwen, Mr. Yu Jianlin, and Mr. Du Mu; and Independent Non-executive Directors Mr. Li Xiangming, Mr. Li Jianjun, and Mr. Chen Chengbei. The company’s board committees are structured as follows: Mr. Li Jianjun chairs the Audit Committee with Mr. Cheng Qianwen and Mr. Li Xiangming as members. Mr. Chen Chengbei chairs the Remuneration and Appraisal Committee, with Ms. Li Runxiang and Mr. Li Jianjun as members. Mr. Li Xiangming chairs the Nomination Committee, with Ms. Li Runxiang and Mr. Chen Chengbei as members. The Strategy Committee is chaired by Mr. An Youcai, with Mr. Cheng Qianwen and Mr. Li Xiangming as members.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02627":"中慧生物-B","BK1161":"生物科技"},"translate_title":"AB&B Bio-Tech Co.Ltd.JS向香港交易所提交董事名单","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02627":0.9},"content_text":"AB&B Bio-Tech Co. Ltd. JS Files Director List with HKEX\n    \n\n        AB&B Bio-Tech Co. Ltd. JS (Stock Code: 2627), a joint stock company established in the People’s Republic of China, has filed its updated list of directors and their roles to the Hong Kong Stock Exchange. The Board consists of Executive Directors Mr. An Youcai (Chairman), Ms. Li Runxiang, and Mr. He Yiming; Non-executive Directors Mr. Cheng Qianwen, Mr. Yu Jianlin, and Mr. Du Mu; and Independent Non-executive Directors Mr. Li Xiangming, Mr. Li Jianjun, and Mr. Chen Chengbei. The company’s board committees are structured as follows: Mr. Li Jianjun chairs the Audit Committee with Mr. Cheng Qianwen and Mr. Li Xiangming as members. Mr. Chen Chengbei chairs the Remuneration and Appraisal Committee, with Ms. Li Runxiang and Mr. Li Jianjun as members. Mr. Li Xiangming chairs the Nomination Committee, with Ms. Li Runxiang and Mr. Chen Chengbei as members. The Strategy Committee is chaired by Mr. An Youcai, with Mr. Cheng Qianwen and Mr. Li Xiangming as members.\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&B Bio-Tech Co. Ltd. JS published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251223-11965407), on December 23, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2593491851","isCrawlerRequest":true}